Sort publications on year
-
Pharmaco - Epidemiology
Cutaneous Infrared Thermometry for Detecting Febrile Patients
HAUSFATER P, ZHAO Y, DEFRENNE S, BONNET P, RIOU B
Emerg Infect Dis ; 14(8):1255-1258
-
Pharmaco-Economics
Costs and persistence of carbonic anhydrase inhibitor versus alpha2 agonists, associated with beta-blockers, in glaucoma an ocular hypertension : an analysis of the UKGPRD database
LAFUMA A, BERDEAUX G
Curr Med Res Opin ; 24(5):1519-1527
-
Pharmaco-Economics
Costs and persistence of brimonidine versus brinzolamide in everyday glaucoma care : an analysis conducted on the UK General Practitioner Research Database
LAFUMA A, LAURENDEAU C, BERDEAUX G
J Med Econ ; 11(3):485-497
-
Pharmaco-Economics
Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by the United Kingdom General Practitioner Research Database
DENIS P, LAFUMA A, BERDEAUX G
Clin Ophtalmol ; 2(2):321-329
-
Pharmaco-Economics
Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients : A French adaptation of CARDS
LAFUMA A, COLIN X, SOLESSE A
Arch Cardiovasc Dis ; 2008;101(5):327-332
-
Pharmaco-Economics
Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France
STANDAERT B, PAREZ N, TEHARD B, COLIN X, DETOURNAY B
Appl Health Econ Health Policy ; 6(4):199-216
-
Pharmaco-Economics
Aspects épidémiologiques et économiques de l’insulinothérapie en Fance métropolitaine
DETOURNAY B
Med Mal Metab ; (2):149-152
-
Pharmaco - Epidemiology
A european survey of patient satisfaction with spectacles after cataract surgery and the associated costs in four European countries (France, Germany, Spain and Italy)
CUQ C, LAFUMA A, JEANBAT V, BERDEAUX G
Ophthalmic Epidemiol ; 15:234-241
-
Pharmaco - Epidemiology
Vasodilators and Nootropics as Predictors of Dementia and Mortality in the PAQUID Cohort
DARTIGUES JF, CARCAILLON L, HELMER C, LECHEVALLIER N, LAFUMA A, KHOSHNOOD B
J Am Geriatr Soc ; 55:395-399
-
Public Health and Epidemiology
Un outil de suivi et d’auto-évaluation du bon usage du médicament en cancérologie : l’observatoire du médicament d la FNCLCC
LATOUR JF, GAMEROFF S, GENEVE J, FAGNANI F
J Pharm Clin ; 26(3):151-157
-
Pharmaco - Epidemiology
Self-reported visual impairment and mortality: a French nationwide perspective
BERDEAUX G, BREZIN AP, FAGNANI F, LAFUMA A, MESBAH M
Ophthalmic Epidemiol ; 14(2):80-87
-
Public Health and Epidemiology
Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity
BANDELLO F, LAFUMA A, BERDEAUX G
Invest Ophtalmol Vis Sci ; 48(1):86-103
-
Public Health and Epidemiology
Prise en charge du diabète en France : des progrès certains
VARROUD-VIAL M, GUERCI B, ATTALI C, SIMON D, DETOURNAY B, HALIMI S, BOUEE S, BRAMI G, FAGOT-CAMPAGNA A, NACHIT-OUINEKH F, ESCHWEGE E, CHARBONNEL B, GRIMALDI A
Réseaux Diabète ; (31):4-9
-
Public Health and Epidemiology
Prévalence et coût du diabète en France : où en est-on?
DETOURNAY B, BRAMI G, NACHIT-OUINEKH F, ESCHWEGE E
Médecine des Maladies Métaboliques ; 1(2):1-4
-
Pharmaco - Epidemiology
La mortalité observée à trois ans dans l’enquête CAROLE
JALLON P, DE ZELICOURT M, FAGNANI F, LAURENDEAU C, FAILLIOT M
Epilepsies ; 2007;19(3):173-177
